ProfileGDS4718 / 222415_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 93% 95% 92% 94% 89% 89% 92% 93% 93% 93% 93% 93% 84% 91% 93% 92% 91% 83% 89% 92% 91% 92% 92% 93% 90% 93% 94% 93% 92% 92% 90% 94% 93% 88% 91% 91% 93% 92% 94% 93% 91% 92% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8553493
GSM549102patient 115, normal, homogenized [OPG study]9.812793
GSM549104patient 119, normal, homogenized [OPG study]10.21395
GSM549108patient 138, normal, homogenized [OPG study]9.4844992
GSM549119patient 077, normal, homogenized [OPG study]9.9317994
GSM549133patient 032, cancer, homogenized [OPG study]9.1764789
GSM549139patient 042, cancer, homogenized [OPG study]9.04989
GSM549099patient 107, normal, homogenized [OPG study]9.572992
GSM549109patient 139, normal, homogenized [OPG study]9.8723993
GSM549110patient 046, normal, homogenized [OPG study]9.7644893
GSM549114patient 063, normal, homogenized [OPG study]9.9104293
GSM549122patient 082, normal, homogenized [OPG study]9.6979693
GSM549134patient 033, cancer, homogenized [OPG study]9.7100293
GSM549136patient 036, cancer, homogenized [OPG study]8.4781684
GSM549140patient 044, cancer, homogenized [OPG study]9.3485591
GSM549111patient 047, normal, homogenized [OPG study]9.9356493
GSM549113patient 057, normal, homogenized [OPG study]9.8115992
GSM549132patient 031, cancer, homogenized [OPG study]9.2744891
GSM549137patient 038, cancer, homogenized [OPG study]8.2738983
GSM549142patient 047, cancer, homogenized [OPG study]8.5872889
GSM549100patient 110, normal, homogenized [OPG study]9.5244292
GSM549107patient 135, normal, homogenized [OPG study]9.5084191
GSM549115patient 068, normal, homogenized [OPG study]9.7989592
GSM549116patient 072, normal, homogenized [OPG study]9.5665792
GSM549120patient 078, normal, homogenized [OPG study]9.8875893
GSM549131patient 030, cancer, homogenized [OPG study]9.2456490
GSM549118patient 074, normal, homogenized [OPG study]9.8436793
GSM549129patient 027, cancer, homogenized [OPG study]9.8463794
GSM549123patient 088, normal, homogenized [OPG study]9.9054793
GSM549124patient 006, cancer, homogenized [OPG study]9.355792
GSM549126patient 015, cancer, homogenized [OPG study]9.4585492
GSM549128patient 025, cancer, homogenized [OPG study]9.1234290
GSM549103patient 117, normal, homogenized [OPG study]9.8820394
GSM549117patient 073, normal, homogenized [OPG study]9.9944993
GSM549138patient 041, cancer, homogenized [OPG study]8.880988
GSM549141patient 045, cancer, homogenized [OPG study]9.4180791
GSM549130patient 028, cancer, homogenized [OPG study]9.2370791
GSM549101patient 111, normal, homogenized [OPG study]9.7428293
GSM549105patient 128, normal, homogenized [OPG study]9.5481392
GSM549106patient 134, normal, homogenized [OPG study]10.035494
GSM549112patient 048, normal, homogenized [OPG study]9.7619993
GSM549125patient 011, cancer, homogenized [OPG study]9.3542291
GSM549127patient 024, cancer, homogenized [OPG study]9.4272492
GSM549135patient 035, cancer, homogenized [OPG study]9.3090390